Vision Outcomes Using Quantitative Optical Coherence Tomography Evaluation in Age Related Macular Degeneration
Sponsor: Stanford University
Listed as NCT02422160, this observational or N/A phase trial focuses on Age-Related Macular Degeneration and remains completed. Sponsored by Stanford University, it has been updated 11 times since 2015, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jun 2022 — Jul 2024 [monthly]
Completed
Status: Recruiting → Completed
-
Oct 2021 — Jun 2022 [monthly]
Recruiting
-
Jan 2021 — Oct 2021 [monthly]
Recruiting
▶ Show 6 earlier versions
-
Aug 2020 — Jan 2021 [monthly]
Recruiting
-
Oct 2019 — Aug 2020 [monthly]
Recruiting
-
Sep 2018 — Oct 2019 [monthly]
Recruiting
-
Jun 2018 — Sep 2018 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
Apr 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Stanford University
For direct contact, visit the study record on ClinicalTrials.gov .